Global Standardized Financials

4.10 -0.29(-6.61%)05/20/2024
Autolus Therapeutics plc (AUTL)

Income Statement
(Values in USD Thousands)
 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31
Net Income-45,849-45,552-39,811-26,951
Revenue4061,2923,825
Cost Of Revenue382
gross Profit241,2923,825
Operating Expenses47,84847,86440,62839,598
Selling General and Administrative Expenses10,61111,1229,2847,412
Research and Development Expenses37,23736,74231,34432,186
Other Expenses-1,5974827826,252
Cost And Expenses47,84847,86440,62839,598
Operating Income-48,230-43,979-35,108-28,095
Interest Income3,6463,4033,4461,426
Income Tax Expense-4,940-3,470-3,970-5,116
Income Before Tax-50,789-49,022-43,781-32,067
Earning Per Share Basic-0.26-0.26-0.23-0.30
Earning Per Share Diluted-0.26-0.26-0.23-0.30
weighted Average Shares Outstanding173,984173,860173,82691,241
weighted Average Shares Outstanding (Diluted)173,984173,860173,82691,241
Gross Margin0.061.001.00
EBIT Margin-108.41-25.70-6.91
Profit Margin-112.93-30.81-7.05
EBITDA-44,014-42,467-33,209-26,446
Earning Before Tax Margin-125.10-33.89-8.38